[How should advanced forms of diffuse infiltrating lung disease be treated: role of new treatments and transplantation indications].
Mal
H
H
Service de Pneumologie B et Transplantation pulmonaire, Hôpital Bichat, Paris. herve.mal@bch.ap-hop-paris.fr
D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000188:drug therapy* / Q000601:surgery; D008175:Lung Neoplasms / Q000188:drug therapy / Q000601:surgery; D016040:Lung Transplantation; D018192:Lymphangioleiomyomatosis / Q000188:drug therapy / Q000601:surgery; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000601:surgery; D011658:Pulmonary Fibrosis / Q000188:drug therapy / Q000601:surgery; D012131:Respiratory Insufficiency / Q000188:drug therapy / Q000601:surgery; D017565:Sarcoidosis, Pulmonary / Q000188:drug therapy / Q000601:surgery